Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) reported Q4 CY2024 results , with sales up 15.7% year on year to $2.91 ...
Semiconductor designer Lattice Semiconductor (NASDAQ:LSCC) in Q4 CY2024, but sales fell by 31.2% year on year to $117.4 ...